Acquired Immunodeficiency Syndrome: all 3,037 studies

Page 7 of 31. Open to participants first (307), then studies with results posted, then the rest; newest registration first within each.

• mVIP (Use of mHealth Technology for Supporting Symptom Management in Underserved Persons Living With HIV)CompletedNCT02897141Not applicableResults posted
• Maraviroc Efficacy for Hepatitis CCompletedNCT02881762Phase 4Results posted
• Trial to Assess the Continued Safety of and Adherence to a Vaginal Ring Containing Dapivirine in WomenCompletedNCT02858037Phase 3Results posted
• Autonomic Neuropathy, GI Motility, and Inflammation in HIVCompletedNCT02850276Early Phase 1Results posted
• Romidepsin Plus 3BNC117 Phase 2a StudyCompletedNCT02850016Phase 2Results posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2)CompletedNCT02831764Phase 3Results posted
• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir Plus Lamivudine With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Subjects (Gemini 1)CompletedNCT02831673Phase 3Results posted
• Measuring and Monitoring Adherence to ART With Pill Ingestible Sensor SystemCompletedNCT02797262Not applicableResults posted
• Resistance Testing to Improve Management of Virologic Failure in Sub-Saharan AfricaCompletedNCT02787499Not applicableResults posted
• Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive AdultsCompletedNCT02741128Phase 2Results posted
• A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)CompletedNCT02738138Phase 3Results posted
• Effects of Doravirine (MK-1439) on Methadone Pharmacokinetics in Methadone-Maintained Participants (MK-1439-045)CompletedNCT02715700Phase 1Results posted
• Healing Hearts and Mending Minds in Older Adults Living With HIVCompletedNCT02711878Not applicableResults posted
• Ibalizumab Plus Optimized Background Regimen in Treatment-Experienced Patients With Multi-Drug Resistant HIV-1CompletedNCT02707861Phase 3Results posted
• Perturbing of HIV Reservoir With Immune StimulationCompletedNCT02707692Not applicableResults posted
• Exercise Training to Improve Brain Health in Older HIV+ IndividualsTerminatedNCT02663934Not applicableResults posted
• Simplification From Tenofovir Plus Lamivudine or Emtricitabine Plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir Plus Lamivudine in Virologically-Suppressed-HIVInfected Adults With OsteopeniaCompletedNCT02652793Not applicableResults posted
• Improving Prognosis in HIV InfectionCompletedNCT02640625Phase 1/2Results posted
• The Compartmental Biology of HIV in the Male Genital TractCompletedNCT02638493Results posted
• A Phase IV, Open Label, 4-period Cross-over Study to Investigate a Drug Interaction Between Lamivudine and Sorbitol Oral Solutions in Healthy VolunteersCompletedNCT02634073Phase 4Results posted
• Effects of Mindfulness Training on Chronic Inflammation in HIV-Infected AdultsCompletedNCT02626949Not applicableResults posted
• Inflammatory Pathogenesis of Coronary Atherosclerosis in HIVCompletedNCT02624180Phase 2Results posted
• SSRI Effects on Depression and Immunity in HIV/AIDSCompletedNCT02620150Phase 4Results posted
• Dutch Acute HCV in HIV Study (DAHHS-2): Grazoprevir/Elbasvir for Acute HCVCompletedNCT02600325Phase 3Results posted
• Steering Together in a New Direction: Reducing the Risk of HIV/STD Among African American MenCompletedNCT02572401Not applicableResults posted
• Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation StudyTerminatedNCT02531295Phase 1Results posted
• Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIVCompletedNCT02495779Not applicableResults posted
• Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult VolunteersCompletedNCT02478463Phase 1Results posted
• Atripla to Stribild Switch Study to Evaluate Sleep DisturbancesCompletedNCT02477527Phase 4Results posted
• Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young AdultsCompletedNCT02474901Phase 2Results posted
• Safety and Pharmacokinetic Study of HIV Prophylaxis Using Antiretroviral Intravaginal Rings in Healthy WomenCompletedNCT02431273Early Phase 1Results posted
• A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected SubjectsCompletedNCT02431247Phase 3Results posted
• Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive AdultsTerminatedNCT02415595Phase 2Results posted
• Phase I, Open Label Dose Escalation Study to Evaluate Safety of iHIVARNA-01 in Chronically HIV-infected PatientsCompletedNCT02413645Phase 1Results posted
• A Safety and Immune Response Study of 2 Experimental HIV VaccinesCompletedNCT02404311Phase 1/2Results posted
• Comparison of Doravirine, Tenofovir, Lamivudine (MK-1439A) and ATRIPLA™ in Treatment-Naive Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Participants (MK-1439A-021)CompletedNCT02403674Phase 3Results posted
• CHAMPS Study: Chronic HepAtitis C Management to ImProve OutcomeSCompletedNCT02402218Not applicableResults posted
• PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIVCompletedNCT02401230Phase 4Results posted
• Mobile Strategies for Women's and Children's Health: Optimizing Adherence and Efficacy of PMTCT/ARTCompletedNCT02400671Not applicableResults posted
• An Extension of Protocol PRO 140_CD01 StudyTerminatedNCT02355184Phase 2Results posted
• Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsCompletedNCT02344680Results posted
• Voluma Filler Agent For The Treatment of HIV-associated Facial LipoatrophyCompletedNCT02342223Phase 1Results posted
• Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of ColumbiaCompletedNCT02339038Phase 4Results posted
• Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) PreventionCompletedNCT02315703Phase 1/2Results posted
• Mobile Media-Rich Interactive Guideline System (MMRIGS) Pilot StudyTerminatedNCT02302859Not applicableResults posted
• Safety & Efficacy of Dual Therapy With Raltegravir/LamivudineCompletedNCT02284035Phase 3Results posted
• Reducing the Burden of Malaria in HIV-Infected Pregnant Women and Their HIV-Exposed Children (PROMOTE-BC2)CompletedNCT02282293Phase 3Results posted
• Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected ParticipantsCompletedNCT02269917Phase 3Results posted
• Economic and Social Empowerment To Increase Upwards Mobility Among WomenCompletedNCT02266108Not applicableResults posted
• Repeat Doses of SB-728mR-T After Cyclophosphamide Conditioning in HIV-Infected Subjects on HAARTCompletedNCT02225665Phase 1/2Results posted
• Comparison of Virologic and Immunologic Responses to Raltegravir and Dolutegravir in the Gastrointestinal Tract of HIV-Positive AdultsCompletedNCT02218320Results posted
• Tesamorelin Effects on Liver Fat and Histology in HIVCompletedNCT02196831Not applicableResults posted
• Open-label Study of Dolutegravir (DTG) or Efavirenz (EFV) for Human Immunodeficiency Virus (HIV) - Tuberculosis (TB) Co-infectionCompletedNCT02178592Phase 3Results posted
• Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 InfectionCompletedNCT02175680Phase 2Results posted
• Phase II Safety and Acceptability of an Investigational Injectable Product, TMC278LA, for Pre-Exposure ProphylaxisCompletedNCT02165202Phase 2Results posted
• Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDSCompletedNCT02155101Phase 3Results posted
• Return to Work Randomized Controlled Trial: Counseling After Fatigue Treatment in HIV/AIDSCompletedNCT02140775Not applicableResults posted
• CASA: Care and Support Access in HIV DiseaseCompletedNCT02136680Not applicableResults posted
• Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade LesionsCompletedNCT02135419Phase 3Results posted
• Effect of Cenicriviroc on HIV Neurocognitive ImpairmentCompletedNCT02128828Phase 2Results posted
• A Phase IIb Study to Evaluate a Long-Acting Intramuscular Regimen for Maintenance of Virologic Suppression (Following Induction With an Oral Regimen of GSK1265744 and Abacavir/Lamivudine) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected, Antiretroviral Therapy-Naive Adult SubjectsCompletedNCT02120352Phase 2Results posted
• A Phase IIIb Study of the Safety, Efficacy, and Tolerability of Switching to a Fixed-dose Combination of Abacavir/Dolutegravir/ Lamivudine From Current Antiretroviral RegimenCompletedNCT02105987Phase 3Results posted
• Texting to Improve Adherence in HIV+ With Bipolar DisorderCompletedNCT02090634Not applicableResults posted
• Elite Controller and ART-treated HIV+ Statin Versus ASA Treatment Intervention StudyCompletedNCT02081638Phase 2Results posted
• Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)CompletedNCT02076178Phase 2Results posted
• ING200336, Pharmacokinetic and Safety Study in Pregnant Women With Human Immuno Virus InfectionCompletedNCT02075593Phase 3Results posted
• Enhancement by Poly-ICLC During HIV-1 InfectionCompletedNCT02071095Phase 1/2Results posted
• Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)CompletedNCT02063880Not applicableResults posted
• Effect of Omega 3 Fatty Acids on Oxidative Stress in HIV Seropositive PatientsCompletedNCT02041520Phase 3Results posted
• A Study to Investigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaCompletedNCT02029430Phase 2Results posted
• Efficacy Study of Different Laboratory Management Strategies and Drug Regimens in HIV-infected Children in AfricaCompletedNCT02028676Phase 4Results posted
• Study of Dapivirine Vaginal Ring (VR) in AdolescentsCompletedNCT02028338Phase 2Results posted
• Quantifying Drug Adherence and Drug Exposure to Antiretroviral TherapyCompletedNCT02012621Results posted
• Safety and Pharmacokinetics of Dapivirine Vaginal Ring in Post-menopausal WomenCompletedNCT02010593Phase 2Results posted
• Theory-based Text Messaging to Reduce Methamphetamine Use and HIV Risks Among MSMCompletedNCT02008526Not applicableResults posted
• Care4Today v2.0 Application for Improving Adherence to HIV MedicationsCompletedNCT02001064Not applicableResults posted
• Phase 3 Open-Label Study to Evaluate Switching From Optimized Stable Antiretroviral Regimens Containing Darunavir to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) Plus Darunavir (DRV) in Treatment Experienced HIV-1 Positive AdultsCompletedNCT01968551Phase 3Results posted
• Efficacy of Tenofovir Alafenamide Versus Placebo Added to a Failing Regimen Followed by Treatment With Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Plus Atazanavir in HIV-1 Positive, Antiretroviral Treatment-Experienced AdultsCompletedNCT01967940Phase 3Results posted
• Real-Time Antiretroviral Therapy Adherence Intervention in UgandaCompletedNCT01957865Not applicableResults posted
• Short-term Disulfiram Administration to Reverse Latent HIV Infection: a Dose Escalation StudyCompletedNCT01944371Phase 1/2Results posted
• A Multipart, Open-label Study to Evaluate the Safety and Efficacy of ABT-450/r/ABT-267 With and Without ABT-333 Coadministered With and Without Ribavirin in Adult With Genotype 1 or 4 Hepatitis C Virus (HCV) Infection and Human Immunodeficiency Virus, Type 1 CoinfectionCompletedNCT01939197Phase 2/3Results posted
• Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy and Switch to an Elvitegravir-based RegimenCompletedNCT01929759Not applicableResults posted
• Two Part Study to Evaluate Pharmacokinetics, Safety, and Antiviral Activity of Elvitegravir Administered With a PI/r Background Regimen for ARV Treatment-Experienced Pediatric ParticipantsTerminatedNCT01923311Phase 2/3Results posted
• Dutch Acute HCV in HIV Study (DAHHS)CompletedNCT01912495Phase 2Results posted
• A Study to Determine Safety and Efficacy of Dolutegravir/Abacavir/Lamivudine (DTG/ABC/3TC) in Human Immunodeficiency Virus (HIV)-1 Infected Antiretroviral Therapy (ART) Naïve Women (ARIA)CompletedNCT01910402Phase 3Results posted
• Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ARTCompletedNCT01869634Phase 4Results posted
• HIV Non-Occupational Post-Exposure ProphylaxisCompletedNCT01855867Phase 4Results posted
• Study to Evaluate the Pharmacokinetics, Safety, and Antiviral Activity of the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Single Tablet Regimen (STR) in HIV-1 Infected Antiretroviral Treatment-Naive Adolescents and Virologically Suppressed ChildrenCompletedNCT01854775Phase 2/3Results posted
• Living Well Project for Persons With AIDSCompletedNCT01848483Not applicableResults posted
• Brief Intervention for Rural Women at High Risk for HIV/HCVCompletedNCT01840722Not applicableResults posted
• Bioequivalence Study of Individual Atazanavir and Cobicistat Compared With Atazanavir in Fixed-dose Combination With CobicistatCompletedNCT01837719Phase 1Results posted
• Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)TerminatedNCT01814722Results posted
• Study to Evaluate a HIV Drug for the Treatment of HIV InfectionCompletedNCT01803074Phase 2Results posted
• Pilot Study of Bydureon to Treat Diabetes in HIV-infected AdultsTerminatedNCT01791465Phase 4Results posted
• Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid TestsCompletedNCT01790633Not applicableResults posted
• Adherence Support Intervention for Persons Living With HIV/AIDS (PLWHA) on Antiretroviral Therapy (ART) in EstoniaCompletedNCT01789138Not applicableResults posted
• Music for Health ProjectCompletedNCT01786148Not applicableResults posted
• A Phase 3, Open-label Study to Investigate the Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2, 3 and 4 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected AdultsCompletedNCT01783678Phase 3Results posted
• Atorvastatin for HAART Suboptimal RespondersCompletedNCT01766076Phase 3Results posted
• Safety Study of a Dual Anti-HIV Gene Transfer Construct to Treat HIV-1 InfectionCompletedNCT01734850Phase 1/2Results posted

← Acquired Immunodeficiency Syndrome overview